Original Research
Accepted on 30 Sep 2025
RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant chemotherapy
in Gynecological Oncology
Original Research
Accepted on 30 Sep 2025
in Gynecological Oncology
Original Research
Accepted on 30 Sep 2025
in Solid Earth Geophysics
Perspective
Accepted on 30 Sep 2025
in Aging and Public Health
Original Research
Accepted on 30 Sep 2025
in Cancer Metabolism
Original Research
Accepted on 30 Sep 2025
in Aging and Public Health
Case Report
Accepted on 30 Sep 2025
in Skin Cancer
Original Research
Accepted on 30 Sep 2025
in Aging and Public Health
Original Research
Accepted on 30 Sep 2025
in Aging and Public Health
Opinion
Accepted on 30 Sep 2025
in Cancer Imaging and Image-directed Interventions
Original Research
Accepted on 30 Sep 2025
in Decision Neuroscience
Case Report
Accepted on 30 Sep 2025
in Human and Medical Genomics
Original Research
Accepted on 30 Sep 2025
in Geoinformatics
Original Research
Accepted on 30 Sep 2025
in Environmental Economics and Management
Conceptual Analysis
Accepted on 30 Sep 2025
in Cognitive Development
Review
Accepted on 30 Sep 2025
in Ethnopharmacology
Review
Accepted on 30 Sep 2025
in Cardiovascular Metabolism